Mingyue Optical Lens Co.Ltd.
Mingyue Optical Lens Co.,Ltd. engages in the research and development, design, and production of lenses, lens raw materials, finished mirrors, frames, and other products in China and internationally. The company offers high refractive index, dual blue light protection, PMC super bright, KR super tough, polarized, intelligent color changing, and progressive multifocus lenses; and customized functi… Read more
Mingyue Optical Lens Co.Ltd. (301101) - Net Assets
Latest net assets as of June 2025: CN¥1.70 Billion CNY
Based on the latest financial reports, Mingyue Optical Lens Co.Ltd. (301101) has net assets worth CN¥1.70 Billion CNY as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.92 Billion) and total liabilities (CN¥216.72 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.70 Billion |
| % of Total Assets | 88.69% |
| Annual Growth Rate | 28.94% |
| 5-Year Change | 204.72% |
| 10-Year Change | N/A |
| Growth Volatility | 59.31 |
Mingyue Optical Lens Co.Ltd. - Net Assets Trend (2019–2024)
This chart illustrates how Mingyue Optical Lens Co.Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Mingyue Optical Lens Co.Ltd. (2019–2024)
The table below shows the annual net assets of Mingyue Optical Lens Co.Ltd. from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.72 Billion | +7.04% |
| 2023-12-31 | CN¥1.60 Billion | +6.06% |
| 2022-12-31 | CN¥1.51 Billion | +4.62% |
| 2021-12-31 | CN¥1.45 Billion | +156.56% |
| 2020-12-31 | CN¥563.28 Million | +17.02% |
| 2019-12-31 | CN¥481.37 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Mingyue Optical Lens Co.Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 499.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥469.89 Million | 28.14% |
| Other Components | CN¥1.20 Billion | 71.86% |
| Total Equity | CN¥1.67 Billion | 100.00% |
Mingyue Optical Lens Co.Ltd. Competitors by Market Cap
The table below lists competitors of Mingyue Optical Lens Co.Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
AES Brasil Energia S.A
SA:AESB3
|
$291.27 Million |
|
PARATUS ENERGY SERVICES LTD
OL:PLSV
|
$291.31 Million |
|
Harworth Group plc
PINK:HWGLF
|
$291.36 Million |
|
Schweizerische Nationalbank
PINK:SWZNF
|
$291.40 Million |
|
Da-Li Development Co Ltd
TW:6177
|
$291.16 Million |
|
Ningbo MedicalSystem Biotechnology Co Ltd
SHE:300439
|
$291.15 Million |
|
ADM Korea Inc.
KQ:187660
|
$291.14 Million |
|
Bear Electric Appliance Co Ltd
SHE:002959
|
$291.09 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mingyue Optical Lens Co.Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,556,526,892 to 1,669,525,835, a change of 112,998,943 (7.3%).
- Net income of 176,785,928 contributed positively to equity growth.
- Dividend payments of 60,219,785 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥176.79 Million | +10.59% |
| Dividends Paid | CN¥60.22 Million | -3.61% |
| Other Changes | CN¥-3.57 Million | -0.21% |
| Total Change | CN¥- | 7.26% |
Book Value vs Market Value Analysis
This analysis compares Mingyue Optical Lens Co.Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.28x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 7.87x to 4.28x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | CN¥4.51 | CN¥35.44 | x |
| 2020-12-31 | CN¥3.49 | CN¥35.44 | x |
| 2021-12-31 | CN¥6.97 | CN¥35.44 | x |
| 2022-12-31 | CN¥7.29 | CN¥35.44 | x |
| 2023-12-31 | CN¥7.72 | CN¥35.44 | x |
| 2024-12-31 | CN¥8.28 | CN¥35.44 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mingyue Optical Lens Co.Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.59%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 22.95%
- • Asset Turnover: 0.41x
- • Equity Multiplier: 1.11x
- Recent ROE (10.59%) is below the historical average (10.75%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 15.39% | 12.64% | 0.88x | 1.38x | CN¥24.45 Million |
| 2020 | 13.28% | 12.97% | 0.77x | 1.33x | CN¥17.27 Million |
| 2021 | 5.85% | 14.26% | 0.36x | 1.14x | CN¥-58.34 Million |
| 2022 | 9.27% | 21.86% | 0.38x | 1.13x | CN¥-10.71 Million |
| 2023 | 10.12% | 21.04% | 0.43x | 1.13x | CN¥1.89 Million |
| 2024 | 10.59% | 22.95% | 0.41x | 1.11x | CN¥9.83 Million |
Industry Comparison
This section compares Mingyue Optical Lens Co.Ltd.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,246,530,775
- Average return on equity (ROE) among peers: 12.28%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mingyue Optical Lens Co.Ltd. (301101) | CN¥1.70 Billion | 15.39% | 0.13x | $291.22 Million |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $2.03 Billion | -9.26% | 2.64x | $356.80 Million |
| Blue Sail Medical Co Ltd (002382) | $10.54 Billion | 10.97% | 0.61x | $760.18 Million |
| Andon Health Co Ltd (002432) | $758.75 Million | 1.34% | 0.32x | $2.33 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $2.75 Billion | 15.67% | 0.82x | $360.97 Million |
| Guangzhou Improve Med Instrument (300030) | $592.55 Million | 4.90% | 0.10x | $242.74 Million |
| Shanghai Tofflon Science Tech (300171) | $2.41 Billion | 11.06% | 0.57x | $802.27 Million |
| Truking Technology Ltd (300358) | $320.32 Million | 29.77% | 1.35x | $556.14 Million |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $1.41 Billion | 16.14% | 0.58x | $438.45 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $1.55 Billion | 13.64% | 0.15x | $1.61 Billion |
| Autek China Inc (300595) | $105.24 Million | 28.59% | 0.10x | $1.21 Billion |